Since the discovery that cyclic AMP mediates the action of a large number and variety of hormones (Sutherland & Robison, 1966) , there has been considerable interest in trying to understand the molecular mechanisms by which hormone occupancy of specific cell surface receptors results in activation of membrane-bound adenylate cyclase, the enzyme responsible for synthesis of cyclic AMP from ATP. Although the earliest concepts of the adenylate cyclase system suggested that hormones might regulate adenylate cyclase activity via binding at allosteric sites on the catalytic moiety, more recently it has been demonstrated that adenylate cyclase systems consist of separable receptor and catalytic subunits (Orly & Schramm, 1976; Limbird & Lefkowitz, 1977; Haga et al., 1977a) and, in addition, a third separable component which confers the multiple regulatory effects of guanine nucleotides on the adenylate cyclase system (for a review focusing on the biochemical properties of the separate components see . The focus of the present review is on these regulatory effects of guanine nucleotides and on the growing body of evidence suggesting that the guanine nucleotide regulatory protein (G-protein) may represent the functional communicator between hormone-occupied receptors and the adenylate cyclase enzyme. The perspective of this review is a historical one; it attempts to summarize the critical observations that established the important role of guanine nucleotides in regulating adenylate cyclase activity and to describe how the further exploration of several apparent enigmas eventually revealed the partial reactions that are involved in receptorcyclase coupling and hormone-induced transmembrane signaling.
The important role ofguanine nucleotides A crucial breakthrough for subsequent studies aimed at understanding receptor-cyclase coupling was the realization that there is an absolute requirement for guanine nucleotides in the stimulation of adenylate cyclase by hormones and drugs. Initially, it was thought that guanine nucleotides were only required to 'enhance' or amplify hormone-stimulated adenylate cyclase. Recognition of the obligatory role of GTP relied on three technological advancements: (1) preparation of membranes washed free of endogenous guanine nucleotide contaminants; (2) the availability of ATP preparations free of contaminating GTP or GDP (e.g. prepared by phosphorylation of adenosine rather than by extraction of skeletal muscle) and (3) inhibition of membrane transphosphorylation of GDP --GTP by utilizing the ATPase-resistant ATP analogue, plNH]ppA, as a substrate for adenylate cyclase. It has now been demonstrated that guanine nucleotides are required for stimulation of adenylate cyclase by virtually all hormones and drugs investigated to date (Cryer et al., 1969; Rodbell et al., 1971a Rodbell et al., ,b, 1974 Rodbell et al., , 1975 Londos et al., 1974; Ross et al., 1977; Williams & Lefkowitz, 1977) . The KO.5 for guanine nucleotide stimulation of adenylate cyclase is in the range of 10-4-10-7M, and typically demonstrates the specificity of p[NH]ppG 2 GTP > GDP> GMP; adenine and pyridine nucleotides are without a significant effect.
Several lines of experimental evidence have established the triphosphate nature of the guanine nucleotide requirement. Most recently, guanosine .5'-[y-thioldiphosphate, a transphosphorylase resistant analogue of GDP, has been employed to demonstrate that GDP is a competitive inhibitor of GTP activation of adenylate cyclase . In certain model systems, e.g. the turkey erythrocyte, GDP cannot mimic or even partially fulfill the role of GTP. In other systems, such as rat liver plasma membranes, GDP appears to facilitate hormone-stimulated adenylate cyclase activity, although at a significantly lower rate than observed with GTP in the same preparations Iyengar & Birnbaumer, 1979) . However, it is still argued whether this effect of GDP represents a low intrinsic activity of the diphosphate nucleotide or is simply a consequence of membrane-catalysed transphosphorylation of GDP to GTP (Kimura & Nagata, 1979) . A second line of evidence suggesting that GTP is the modulator of hormonal responsiveness in vivo is derived from studies using mycophenolic acid, an inhibitor of IMP dehydrogenase, to decrease intracellular GTP levels. An 80% reduction in intracellular GTP levels results in a concomitant 40-70% loss in responsiveness to catecholamines in C6 glioma cells (Franklin & Twose, 1977) , Erlich ascites tumour cells and NRK cells (Johnson & Mukku, 1979) and a 50%o decrease in the stimulated production of cyclic AMP by prostaglandin E1 in NRK cells (Johnson & Mukku, 1979 (Londos et al., 1974 (Londos et al., , 1977 Speigel et al., 1977) . It was demonstrated that these analogues were not only capable of facilitating hormone activation of adenylate cyclase but could also stimulate adenylate cyclase independently of hormones in some tissues. Inherent in the results from studies with the hydrolysis-resistant analogues of GTP was the conclusion that, despite the apparent requirement for a triphosphate guanine nucleotide in mediating hormone activation of adenylate cyclase, the terminal phosphate apparently need not be hydrolysed for participation in phosphorylation or pyrophosphorylation reactions.
The kinetics of activation of adenylate cyclase in the presence of the hydrolysis-resistant analogues were characterized by two unique features when compared with the effects of native GTP: (1) the activation of the enzyme proceeded after a considerable lag which could be shortened or eliminated by increasing the concentration of hormone added to the analogue-containing incubation (Londos et al., 1974) and (2) the stimulated activity of adenylate cyclase obtained with hydrolysis-resistant analogues appeared 'irreversible' and was stable to multiple washes of the membranes as well as to solubilization by detergents (Schramm & Rodbell, 1975; Londos et al., 1974;  Lefkowitz, 1974; Lefkowitz & Caron, 1975 (Frieden, 1970) . First, the lag might be due to a slow isomerization between two activity states of the enzyme, and the role of hormone in reducing the hysteresis would in this case be due to increasing the rate of isomerization to the active state of the enzyme (Birnbaumer et al., 1980b) . Alternatively, the lag in stimulation by p[NH]ppG could also be accounted for by the time required for endogenous nucleotides to dissociate from the GTP-binding site.
Shortening of the lag in p[NH]ppG stimulation by hormone could then result from a hormone-stimulated release of endogenous nucleotides and/or exchange at the GTP binding site (Blume & Foster, 1976) . This latter possibility was approached directly by Cassel & Selinger (1977a , 1978 (Cassel & Selinger, 1978) . Most importantly, however, was the Qbservation that catecholamines could facilitate the release of bound GDP and this was interpreted as representing the mechanism by which hormones accelerate the activation of adenylate cyclase by p[NH]ppG (Cassel & Selinger, 1977b , 1978 Lad et al., 1980; Swillens et al., 1979) . Consistent with this interpretation are observations that pretreatment of turkey erythrocyte membranes with isoproterenol and GMP prior to extensive membrane washing results in a preparation of adenylate cyclase which is responsive to pINH]ppG in the absence of hormones without an apparent lag . GMP (Cassel & Selinger, 1977b , 1978 . This apparent co-operativity suggests that the regulatory component conferring guanine nucleotide sensitivity to the adenylate cyclase system either has more than one nucleotide binding site, or is multimeric or both.
Despite the clear ability of hormones to facilitate release of GDP or exchange of guanine nucleotides at the regulatory site, there is still argument concerning the rate-limiting step in the activation of adenylate cyclase by hormones (Levitzki, 1980a) . Bimbaumer and colleagues (Birnbaumer et al., 1980a,b; Iyengar et al., 1980) (Strittmatter & Neer, 1980 (Cassel & Selinger, 1977b , 1978 , and also regulate the expression of adenylate cyclase activity.
A second aspect of the kinetics of activation of adenylate cyclase that subsequently provided additional insights into the partial reactions involved in regulation of the adenylate cyclase system was the apparent 'irreversibility' or persistence of activation of p [NH] ppG (Lefkowitz, 1974; Lefkowitz & Caron, 1975; Schramm & Rodbell, 1975; Bennett & Cuatrecasas, 1976) . Coupled with the finding that GDP was the major nucleotide released from hormone-treated membranes (Cassel & Selinger, 1978) , the 'irreversibility' or the activation of adenylate cyclase by hydrolysis-resistant analogues suggested that the hydrolysis of GTP might terminate the activation of adenylate cyclase. {Actually, 'irreversibility' is a misnomer. Consistent with the ability of hormones to facilitate the exchange of guanine nucleotides at the G-protein, incubation of p[NH]ppG-preactivated membranes with hormone and GTP reduces preactivated catalytic activity to that characteristic of hormone + GTP in certain systems studied (Londos et al., 1977; Cassel & Selinger, 1977b; Sevilla & Levitzki, 1977; Sevilla et al., 1976.4 Consistent with the prediction that a GTP hydrolysis function is involved in regulating the adenylate cyclase system, Cassel & Selinger (1976) were able to demonstrate the existence of a catecholamine-stimulated GTPase activity in turkey erythrocyte membranes. Despite a high 'background' GTPase activity, these investigators noted a 30-70% stimulation of hydrolysis by catecholamines. The apparent affinity for GTP and isoproterenol in the GTP-hydrolysis reaction is comparable with the apparent affinities of these agents in modifying adenylate cyclase activity. The putative relationship of the catecholamine-sensitive GTPase to the function of adenylate cyclase was further corroborated by the observation that isoproterenol-stimulated GTPase was inhibited by p[NH]ppG and by cholera toxin (Cassel & Selinger, 1977a) , both agents that promote an apparently irreversible activation of adenylate cyclase. On the basis of these observations, Cassel et al. (1977) postulated that activation of adenylate cyclase involves occupancy by GTP, or a guanosine triphosphate analogue, and that the hydrolysis of GTP to GDP represents the 'turnoff mechanism by which the catecholamine-sensitive system relaxes. Catecholamine-stimulated GTPase activity has subsequently been detected in frog erythrocyte membranes and appears to be correlated with both activation and desensitization of the adenylate cyclase system. Thus, when the frog erythrocyte is desensitized by incubation with 10-4M-isoproterenol, decreases in catecholaminestimulated adenylate cyclase are paralleled by decreases in both isoproterenol-stimulated GTPase and fi-adrenergic receptor binding activities. Interestingly, incubation of turkey erythrocytes with 10-4M-isoproterenol results in a loss of both catecholamine-stimulated adenylate cyclase and GTPase activities but no decrease in receptor binding. GTPase activities sensitive to prostaglandin El (Bitonti et al., 1980) , secretin and pancreozyminrelated peptides (Lambert et al., 1979) and glucagon (Kimura & Shimada, 1980) have now been observed in membranes from human mononuclear cells, rat pancreas and rat liver, respectively. In the case of the membranes from mononuclear cells (Bitonti et al., 1980) , there is an apparently poor correlation Vol. 195 between prostaglandin stimulation of GTPase and adenylate cyclase activities. However, in trying to relate the responsiveness of adenylate cyclase to hormone-stimulatable GTPase activity, it is important to remember that the apparent GTPase activity may represent both a genuine increase in Vmax stimulated by hormone, as well as a hormonefacilitated replenishment of GTP at the substrate binding site secondary to hormone-facilitated guanine-nucleotide exchange. The extent to which one or the other of these reactions 'dominates' will no doubt affect the extent to which hormonestimulated adenylate cyclase activity appears to be related to hormone-modified GTPase activity. For systems in which hormone-sensitive GTPase activity is not easily measured directly, Cassell et al. (1977, 1979) have described a kinetic approach by which the rate of cyclase 'turnoff' can be calculated.
Effect of guanine nucleotides on receptor interactions with hormones and agonist drugs
Since it had been observed that hormones and agonist drugs accelerate the rate of interaction of GTP with adenylate cyclase systems, it was expected that guanine nucleotides might modify the kinetics of receptor-hormone interactions. The availability of radioactively labelled hormones and drugs that specifically identify their physiologically relevant receptors allowed the effect of guanine nucleotides on receptor-hormone interactions to be measured directly. The ability of guanine nucleotides to increase the rate of dissociation of hormone from the receptor was first observed with receptors for glucagon in rat liver membranes (Rodbell et al., 1971a; Lin et al., 1977) . This increased rate of dissociation is paralleled by a decrease in receptor affinity (KA = k0l/k0ff) for hormones. In catecholamine-stimulated adenylate cyclase systems, for which both radiolabelled agonists and antagonists are available to identify the fi-adrenergic receptor, it has been demonstrated that guanine nucleotides only decrease receptor affinity for agonists and do not modify receptor-antagonist interactions (Maguire et al., 1976; Lefkowitz et al., 1976) . A decrease in receptor affinity for agonists is most easily investigated by studying the competitive binding of unlabelled agonist for radiolabelled antagonist in the presence and absence of added guanine nucleotides. In the absence of added nucleotides, the agonist competition curve is usually abnormally shallow, suggesting a heterogeneity of receptor-agonist interactions. The addition of guanine nucleotides shifts the competition curve to the right, consistent with a reduction in receptor affinity for agonists, and to normal steepness (i.e. pseudo-Hill coefficient approx. 1.0), consistent with receptor-agonist interactions obeying a simple mass action law. This phenomenon has been observed in a number of target membranes.
Computer analysis of agonist competition for the binding of [3Hldihydroalprenolol to frog erythrocyte fJ-adrenergic receptors indicates that the shallow competition-binding curve, possessing an overall higher potency of agonist in the absence of guanine nucleotides, is consistent with occupancy of the receptors by agonists inducing a higher-affinity state of the receptor for a certain fraction of the receptor population (Kent et al., 1980) . Guanine nucleotides decrease the fraction of the agonist-occupied receptors in the higher affinity state in a concentrationdependent manner and, at maximal concentrations (e.g. 0.1 mM-GTP), convert all of the agonistoccupied receptors to the lower-affinity state, thus providing an explanation for the observation that agonist competition curves are shifted to the right and are of normal steepness in the presence of guanine nucleotides (Kent et al., 1980) . Within a particular target system, the extent of the guanine nucleotide-induced shift in receptor affinity is directly proportional to the intrinsic activity of the atonist in stimulating adenylate cyclase (Lefkowitz et al., 1976) . The detection of agonist-promoted receptor interactions of higher affinity which are reversed by guanine nucleotides is variable with different target membranes. Thus, guanine nucleotide-promoted shifts in receptor affinity for agonist are more prominent in membranes from S49 lymphoma cells (Ross et al., 1977; Maguire et al., 1976) , frog erythrocytes (Lefkowitz et al., 1976) , and rat reticulocytes (Limbird et al., 1980) than, for example, in membranes from turkey erythrocytes (Limbird et al., 1979a; Lad et al., 1980) . However, pre-treatment [e.g., isoproterenol and GMP ] of turkey erythrocyte membranes under conditions that are intended to decrease contamination with endogenous nucleotides enhances the ability to detect both higher affinity agonistreceptor interactions and GTP-promoted decreases in receptor affinity. Thus, the majority of target systems studied to date appear to be qualitatively similar with regard to the ability of guanine nucleotides to modulate receptor-hormone or receptor-agonist interactions, but may differ quantitatively in this respect, presumably because of different intrinsic rate constants for certain of the partial reactions that occur after the receptor is occupied but before adenylate cyclase is activated. Pfeuffer (1977) originally reported that this 42 000 Mr G-protein could be removed from the membrane with EDTA, suggesting that this moiety is an 'extrinsic' membrane protein Yu et al., 1973) ; this has not been confirmed by others. Instead, the G-protein meets the criteria for an 'intrinsic' membrane protein . Hydrodynamic studies on the detergent-solubilized G-protein have suggested that it (Howlett & Gilman, 1980; Kaslow et al., 1980) binds less detergent than do the catalytic (Neer, 1978; Haga et al., 1977) or receptor (Haga et al., 1977) moieties of the adenylate cyclase system in the same target membrane. These findings are consistent with the hypothesis that the G-protein possesses a relatively small hydrophobic surface area and may therefore not penetrate very far into the biological membrane. Unequivocal determination of the surface area of the G-protein and the nature of its interaction with target membranes, especially as regulated by hormones, GTP and/or NaF, will require studies with purified material in carefully defined reconstituted systems.
Confidence that the 42 000-Mr species isolated by Pfeuffer was the G-protein that confers guaninenucleotide sensitivity to the adenylate cyclase system was bolstered by the almost simultaneous discovery that cholera toxin catalyses the ADP-ribosylation of a 42000-Mr peptide in target membranes (Gill & Meren, 1978; Cassel & Pfeuffer, 1978; Johnson et al., 1978; Moss & Vaughan, 1979) . Cholera toxin had long been known to activate adenylate cyclase persistently by a mechanism predicted (Levinson & Blume, 1977) , and later demonstrated, to be due to an inhibition of the hydrolysis of GTP in the adenylate cyclase system (Cassel & Selinger, 1977b) . Thus, following exposure to cholera toxin, GTP behaves like the hydrolysis-resistant analogue p[NH]ppG in producing a persistent activation of adenylate cyclase. Gill & Meren (1978) and others (Cassel & Pfeuffer, 1978; Johnson et al., 1978) demonstrated that incubation of broken cells with cholera toxin and [32P]NAD+ resulted in a transfer of [32P]ADP-ribose to a 42000-M, peptide. The extent of the covalent modification of this peptide was related to increments in the cholera-toxinpromoted activity of GTP-sensitive adenylate cyclase activity and to decrements in the NaF-sensitive adenylate cyclase activity and the inhibition of catecholamine stimulated GTPase activity. More recently, Lad et al. (1980) have argued that cholera-toxin-catalysed ADP-ribosylation also enhances the rate of exchange at the GTP-binding site. If true, this effect would not only contribute to an increase in GTP-sensitive adenylate cyclase but would also explain the increased affinity of toad erythrocyte ,B-adrenergic receptors for agonists in membranes previously exposed to cholera toxin (Fisher & Sharp, 1978) , since the ability of agonist occupying the receptor to induce a high-affinity agonist-receptor complex would be facilitated by decreased contamination of the membranes by endogenous nucleotides.
Perhaps the most important consequence of the discovery of the catalytic function of cholera toxin is the ability to identify specifically the G-protein in functional association with adenylate cyclase systems by using [ 32PIADP-ribose as a covalent marker. The precise number of [ 32P]ADP-ribose moieties incorporated per 42000-M, subunit is not yet known, but the ratio of mol of [32P]ADP-ribose incorporated per mol of f,-adrenergic receptor in several target membranes is 1: 1 to 8: 1 (Gill & Meren, 1978; Cassel & Pfeuffer, 1978; Johnson et al., 1978; Kaslow et al., 1979; Limbird et al., 1980b) . This is a considerably more conservative ratio than the 20-100: 1 ratio obtained with [H]-guanine nucleotide binding as an estimate of G-protein quantity (e.g. Speigel & Aurbach, 1974; Lefkowitz, 1975 hormone and nucleotide effectors impinging on the system. This possibility has recently been strengthened in studies demonstrating that the apparently 'excess' G-proteins can restore the sensitivity to guanine nucleotides of isolated catalytic subunits in reconstitution experiments (Strittmatter & Neer, 1980) . Genetic manipulation and reconstitution have provided another avenue for functionally and physically isolating the G-protein, as well as for beginning to identify the nature of its interaction with other components of the adenylate cyclase systems. Mutants of S49 lymphoma cells with functional defects in the adenylate cyclase system are isolated by their resistance to the cytotoxic effects of intracellular cyclic AMP that is elevated in response to isoproterenol or cholera toxin (Daniel et al., 1973; Bourne et al., 1975; Haga et al., 1977b) . Two categories of mutants have been particularly important for furthering the understanding of adenylate cyclase, the AC-mutant (discovered and termed cyc-by Bourne et al., 1975) and the UNC mutants (Haga et al., 1977b) . Both the AC-and the UNC mutants possess JJ-adrenergic and prostaglandin E1 receptors and the catalytic subunit of the adenylate cyclase system. However, the AC-mutant lacks a G-protein, at least as far as can be established by using any existing functional or structural criteria (Bourne et al., 1975; Ross & Gilman, 1977a,b; Johnson et al., 1978) . As a consequence, catalytic activity in AC-membranes is detectable only in the presence of the artificial substrate, Mn2+-ATP, and no responsiveness to guanine nucleotides, NaF, hormones or cholera toxin is demonstrable (Ross et al., 1978) . G-proteins from wild-type S49 lymphoma membranes (Ross et al., 1978; Howlett et al., 1979) and other sources (Ross & Gilman, 1977a,b) Sternweis et al., 1981) . The assay for the G-protein during purification was the functional reconstitution of p[NH]ppG-stimulated and NaF-stimulated adenylate cyclase to AC-preparations. The G-protein complex isolated from rabbit liver membranes appears to consist of three non-identical subunits of Mr approx. 52000, 45000 and 35000 associated in an unknown stoichiometry. The G-protein from turkey erythrocytes possesses only the 45000 and 35000 Mr species (Sternweis et al., 1981) . The possible relationship of these subunits to the overall function of the G-protein is as follows. The 45000-Mr subunit is undoubtedly the same as the 42000-Mr species identified by Pfeuffer with the PHIazido-anilide analogue of GTP, and responsible, at least in part, for restoring p[NH]ppG-stimulated and NaF-stimulated activity to the catalytically active preparation, deficient in regulatory proteins, that is obtained after exposure to a GTP-Sepharose resin (Pfeuffer, 1977) . The 45 000-Mr subunit is clearly a substrate for ADP-ribosylation by cholera toxin both in native membranes and following reconstitution of purified G-proteins into ACacceptor membranes. Interestingly, the purified G-protein isolated from membranes is not a substrate for cholera toxin-catalysed ADP-ribosylation, since it requires the presence of additional 'factors' to be covalently modified (Sternweis et al., 1981 ).
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One factor, possessing a Stokes' radius corresponding to a globular protein of Mr approx. 50000, can be solubilized from rabbit liver or turkey erythrocyte membranes, and does not appear to correspond to the active catalytic subunit of adenylate cyclase. The relationship of this membraneprovided factor to the approx. 20000-Mr cytosolic factor previously reported to facilitate ADP-ribosylation catalysed by cholera toxin (Enomoto & Gill, 1980) is not yet known. Nor is it known if the 50000-Mr 'factor' might represent yet another component, not previously identified, of the membrane-bound adenylate cyclase system. The 52000-M, subunit of the G-protein is also ADP-ribosylated by cholera toxin (Kaslow et al., 1979; Northup et al., 1980) . This particular subunit is not observed in turkey erythrocyte membranes or human erythrocyte membranes treated with [32p]_ NAD+ and cholera toxin (Kaslow et al., 1979) and, as mentioned above, cannot be detected as a subunit of the G-protein purified from turkey erythrocyte membranes by either [ 32P]ADP-ribosylation or protein staining techniques (Sternweis et al., 1981) . Since both human and turkey erythrocyte Gproteins nevertheless restore NaF and guanine nucleotide sensitivity to AC-acceptor membranes, the 52000-M, subunit is clearly not essential for G-protein activity. Actually, the characteristics of adenylate cyclase in native turkey erythrocyte membranes or AC-membranes reconstituted with turkey-erythrocyte G-proteins suggest that the 52000-Mr subunit may be more closely aligned, both physically and functionally, with hormone receptors, or at least with guanine nucleotide exchange reactions. Thus, the intrinsic rate of guanine nucleotide exchange appears to be virtually zero in turkey erythrocyte membranes except in the presence of hormone (Cassel & Selinger, 1977a , 1978 , and this stubborn exchange is paralleled by a trivial effect of p[NH]ppG and GTPyS on the catalytic activity of adenylate cyclase in turkey erythrocytes unless isoproterenol is simultaneously present to accelerate the rate of guanine nucleotide interaction with the cyclase system (Cassel et al., 1977; Kaslow et al., 1979; Lad et al., 1980) . Similarly, AC-membranes reconstituted with turkey erythrocyte G-proteins demonstrate the same stringent requirement for isoproterenol for stimulation of cyclic AMP synthesis by GTP and GTPyS, in distinct contrast to observations in AC-membranes reconstituted with wild type S49 G-proteins (Kaslow et al., 1979) . To continue this speculation, the 52 000-Mr subunit may represent the additional binding site for GTP that provides for guanine nucleotide exchange facilitated by GTP (Cassel & Selinger, 1977a , 1978 , since it should be remembered that analogue did identify a 53000-Mr component of pigeon erythrocyte membranes (Pfeuffer, 1977) . Certainly, reconstitution studies with purified Gproteins differing in their stoichiometry of 52000-Mr: 45000-Mr subunits will resolve some of these questions. Of further interest are the data of Hudson & Johnson (1980) , which demonstrate that the peptide map of the 52000-M, subunits shows considerable overlap with that of the 45 000-Mr subunit and, furthermore, that a 45 000-Mr product can be obtained by mild proteolysis of the 52000-M, subunit. These data suggest that the 52000-Mr subunit may be a precursor of the 45 OOO-Mr form.
The role of the 35 000-M, subunit is least understood, but it is considered to be an integral part of the G-protein since it cannot be resolved from the other two subunits except by conditions that inactivate the reconstituting ability of the 45 000-Mr and 52000-M, subunits (Sternweis et al., 1981) .
Perhaps the 35000-M, species is critical for interaction of the G-protein with other protein components of the adenylate cyclase system or with the lipid milieu of the target membrane.
At present, the stoichiometry of the three subunits of the G-protein comprising a functional complex is not clear. Hydrodynamic studies of the partially purified G-protein suggest that the complex behaves with an apparent molecular mass of 130000 daltons.
Pre-activation with p[NH]ppG or NaF decreases the sedimentation coefficient of the G-protein consistent with a decrease in mass of 40000 daltons (Howlett & Gilman, 1980 Even before the recent availability of techniques for purifying the G-protein, there has been considerable interest in the sequence of molecular events that accompany hormone interaction with the adenylate cyclase system. Limbird and colleagues demonstrated that agonist occupancy of ,B-adrenergic receptors in frog erythrocyte (Limbird & Lefkowitz, 1978) and rat reticulocyte (Limbird et al., 1980a) membranes caused a physical coupling of the fJ-adrenergic receptor with the G-protein, identified by [32P]ADP-ribosylation catalysed by cholera toxin (Limbird et al., 1980a (Limbird et al., 1979c) . The co-elution of the f,-adrenergic receptor with [32PIADP-ribosylated G-proteins, whose covalent modification parallels increases in GTP-sensitive adenylate cyclase activity, suggests that the same G-protein, or population of G-proteins, modulates both receptor affinity and catalytic activity. A similar conclusion has been reached on theoretical grounds (Levitzki 1980b) and is corroborated by the parallel restoration of hormone-sensitive cyclase activity and guanine nucleotide modulation of receptor affinity that occurs upon the reassociation of G-proteins with AC-or UNC mutants of S49 lymphoma cells (Ross et al., 1978; Sternweis & Gilman, 1979) . Furthermore, Stadel & Lefkowitz (1981) have provided additional evidence that a single G-protein population modifies both receptor and catalytic functions. These investigators isolated G-proteins associated with agonist-occupied receptors by absorbing the complexes to wheat-germ agglutinin-Sepharose and then eluting the Gproteins with GTPyS. The G-proteins thus eluted allowed adenylate cyclase to be stimulated in solubilized preparations from turkey erythrocytes previously devoid of sensitivity to exogenous guanine nucleotides.
In much the same way that agonist occupancy of the fi-adrenergic receptor appears to promote or stabilize receptor-G-protein interactions, the occupancy of G-protein by GTPyS, but not by GDP, promotes formation of a stable complex of G-protein with C (the catalytic component) that can be isolated by sucrose-gradient centrifugation (Pfeuffer, 1979) . This coincides with the ability of guanine nucleotides to stabilize the interaction of the Gprotein with AC-and UNC acceptor preparations in reconstitution studies (Ross et al., 1978; Howlett et al., 1979; Sternweis & Gilman, 1979) . Concomitant with this interaction of G-protein with C is an increase in the affinity of the G-protein for bound guanine nucleotides Strittmatter & Neer, 1980) . Fig. 1 provides a schematic diagram of the postulated interactions between the known molecular components of the adenylate cyclase system in the presence of hormones and guanine nucleotides, which is based on the kinetic, molecular and reconstitution studies described throughout this review. Occupancy of the receptor by agonist promotes or stabilizes an interaction between the receptor and the G-protein (Limbird & Leflowitz, 1978; Limbird et al., 1980a) . This interaction represents the high-affinity state of the receptor for agonists and provides a molecular basis for the release of GDP from the regulatory protein (Cassel & Selinger, 1977b , 1978 . Binding of presumably ambient GTP simultaneously dissociates the R-G-protein complex (Limbird et al., 1980a) , which results in a homogeneous population of dissociated receptors possessing a lower affinity for agonist , and promotes or stabilizes the association of the G-protein with C (Pfeuffer, 1979) . Synthesis of cyclic AMP continues until GTP is hydrolysed by the GTPase 'turnoff' reaction (Cassel et al., 1977) , thus leaving GDP on the G-protein and reducing the affinity of the G-protein-C interaction (Pfeuffer, adenylate cyclase activity based on data summarized in this review R, receptor for hormones and drugs; G, G-protein conferring sensitivity to guanine nucleotides; C, catalytic component.
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. What is emphasized in this scheme is the pivotal role of the G-protein in communicating between the agonist-or hormone-occupied receptor and the catalytic subunit of adenylate cyclase. The obligatory role of the initial R-G-protein interaction as a prerequisite for hormone-stimulated adenylate cyclase activity is indicated by several lines of evidence. First, the AC-mutant of S49 lymphoma cells does not possess a functional G-protein and is devoid of hormone-sensitive adenylate cyclase activity. Secondly, rat reticulocyte membranes possess an easily demonstrable complex of receptor with G-protein, promoted by agonists, which correlates with the marked stimulation of the adenylate cyclase in reticulocytes by isoproterenol or p[NHlppG (Limbird et al., 1980a) . In contrast, this agonistpromoted complex cannot be demonstrated in mature rat erythrocyte membranes, where adenylate cyclase activity is significantly less sensitive to catecholamines or p[NHIppG than in reticulocyte preparations (Limbird et al., 1980b (Citri & Schramm, 1980) . Finally, although the scheme in Fig. 1, and (Tolkovsky & Levitzki, 1978) may represent an appropriate description of the molecular events involved between fi-adrenergic receptor occupancy and adenylate cyclase activation.
The ability of agonists to promote the formation of an R-G-protein complex corresponds to the ability of agonist to form a high-affinity state of the receptor Limbird et al., 1980a) . The coexistence of agonist-R-G-protein and agonist-R complexes in the target membrane provides a molecular explanation for the shallow curves characteristic of agonist competition for antagonist binding . The ability of guanine nucleotides to shift agonist competition curves to the 'right' and to normal steepness parallels the ability of guanine nucleotides to dissociate the R-G-protein complex (Limbird et al., 1980a) , generating a homogeneous population of receptors of lower affinity for agonists. Consistent with the interpretation that an R-G-protein complex represents the high-affinity state of the receptor are observations with AC-and UNC mutant membranes, where the functional absence of a G-protein (AC) or presence of a defective G-protein (UNC) is associated with the absence of shallow, higher affinity competition curves for agonist. Instead, agonist-competition curves for receptor binding in these mutant membranes are of normal steepness, exhibit the lower affinity characteristic of wild-type membranes in the presence of guanine nucleotides, and are not modulated by the addition of guanine nucleotides to the incubation medium (Ross et al., 1977) . Studies with perturbants of the adenylate cyclase system that uncouple the communication of either R to G-protein (Pike & Lefkowitz, 1978; or G-protein to C (Limbird et al., 1979b; provide data that are entirely consistent with observations on the genetic mutants of the S49 lymphoma line. The functional stoichiometry of the components of the adenylate cyclase system implied in Fig.  1 (R1:01: C1) has not yet been documented by biochemical findings, but has been predicted by computer-modelling studies . Another complexity of the system, i.e. the stoichiometry of the 52000-, 45000-and 35000-Mr subunits within the functional G-protein complex, has not yet been established but this is likely to be an important regulatory factor that determines the responsiveness of an adenylate cyclase system (Sternweis et al., 1981) .
Another experimental approach employed in an attempt to understand the molecular architecture of the adenylate cyclase system is target-size analysis after high-energy radiation inactivation (Houslay et al., 1977; Schlegel et al., 1979) . In this technique, membranes are irradiated with high-energy electrons, and the quantity of energy or duration of exposure required to inactivate a measured function (e.g. receptor, binding or cyclase activity) is thought to correlate with the volume or size of the structure required for the measured function in the membrane (Lea, 1955; Kempner & Schlegel, 1977) . The presumed appeal of this approach is that the effect of Vol. 195 hormones and guanine nucleotides on molecular associations within the adenylate cyclase system can be evaluated without disruption of the membrane by detergents; however, the use of lyophilized membranes and/or cold (-1100C) conditions for irradiation cannot be assumed not to cause perturbations at the time of analysis that are not detectable in the assay of subsequently rehydrated or thawed samples. Perhaps it is the lack of definition and/or control over these experimental variables that is responsible for the apparently contradictory conclusions drawn from target-size analysis of a single model system, the glucagon-sensitive adenylate cyclase of rat liver. Thus, the findings of predict that the regulatory components remain associated with the catalytic subunit when it is in its activated state, whereas the findings of Martin et al. (1980) 
Bimodal regulation ofadenylate cyclase by GTP
In addition to a crucial role in activating adenylate cyclase, GTP has also been demonstrated to inhibit adenylate cyclase both in the presence and absence of hormones. The bimodal regulation of adenylate cyclase has been studied most rigorously in the fat-cell system (Harwood et al., 1973; Rodbell, 1975; Yamamura et al., 1977; Cooper et al., 1979; Londos etal., 1981) .
For systems in which GTP both activates and inhibits adenylate cyclase, the Ko5 for GTP activation is usually 10-100-fold lower (higher affinity) than the Ko.5 for GTP inhibition of adenylate cyclase. The apparent inhibition by GTP at high concentrations is presumably not due to an accumulation of inhibitory GDP, since GDP alone will not support the inhibitory phase (Harwood et al., 1973 (Yamamura et al., 1977) , divalent cations (Cooper et al., 1979) and treatment with mercurials (Cooper et al., 1979) , opiate, muscarinic and a-adrenergic attenuation of prostaglandin El-stimulated adenylate cyclase in NG 108-15 cells (Sharma et al., 1977; Nathanson et al., 1978; Sabol & Nirenberg, 1979 ) and a-adrenergic attenuation of prostaglandin El stimulation of adenylate cyclase in human platelets Steer & Wood, 1979) . It should be stressed that receptors that are distinct from those coupled to activation of adenylate cyclase are involved in attenuation of catalytic activity. In a recent review on hormonal inhibition of adenylate cyclase, Jakobs (1979) tabulated the generalizations that can be drawn from the present data. (1) Hormone-induced inhibition of basal or hormone-stimulated adenylate cyclase is never complete, and 40-60% of the control activity is typically retained in the presence of attenuating hormones. (2) 40mM; Na+ Li+ > K+) is either required for, or enhances, the apparent attenuation of adenylate cyclase in most of the systems studied. One role for Na+ appears to be elimination of the GTP inhibitory phase of nucleotide regulation, so that inhibition of adenylate cyclase by the attenuating hormone is more apparent (Londos et al., 1981) .
Despite the differences between the activating and attenuating hormone systems, the requirement for GTP in hormonal attenuation of adenylate cyclase and the ability of GTP to modulate attenuating receptor affinity for agonists is reminiscent of the effects of guanine nucleotide on activating systems. The similarities observed for the effects of GTP in activating, and attenuating, adenylate cyclase naturally suggest the possibility that similar molecular interactionis may account for the effects of guanine nucleotides.
1981
Computer analysis of the modulation of the affinity of human platelet a-adrenergic receptors for agonists by guanine nucleotides suggests that a ternary complex of agonist-receptor-G-protein exists for the human platelet a-receptor similar to that described for f-adrenergic receptors coupled to activation of adenylate cyclase (Hoffman et al., 1980) . Furthermore, agonist occupancy of the human platelet a-adrenergic receptor appears to stabilize these receptor-effector interactions occurring in the membrane to solubilization by detergent, since agonist-receptor complexes can be resolved from unoccupied or antagonist-occupied aadrenergic receptors by their faster sedimentation in sucrose gradients (Smith & Limbird, 1981) . Despite the suggestion from these preliminary data that a similar sequence of molecular events may accompany both activation and attenuation of adenylate cyclase, an important question still remains, and that is whether the same, or distinct, G-proteins confer activating and attenuating signals to the adenylate cyclase enzyme.
Summary offuture questions
Even without purified components of the adenylate cyclase system, data emerging from a number of experimental approaches in several target systems suggest that a qualitatively similar mechanism for activation of adenylate cyclase exists in all target tissues, especially those tissues regulated by ,6-adrenergic catecholamines. Thus, the flow of information appears to proceed from the receptor through the G-protein to the catalytic moiety, and a single population of G-proteins appears to modify both receptor-agonist interactions and the catalytic activity of adenylate cyclase. Model systems once felt to represent an 'exception' to the typical scheme envisaged for regulation of the adenylate cyclase system by hormones and guanine nucleotides, e.g. the turkey erythrocyte, are now thought instead to represent an extreme on a continuum. Thus, the lack of immediate effects of p[NH]ppG on catalytic activity and receptor-agonist interactions in turkey erythrocyte membranes appears to result from a hormone-dependent guanine nucleotide exchange reaction at the G-protein rather than the more typical hormone-facilitated exchange reaction . Consequently, it now seems reasonable to conclude that all systems utilize a qualitatively similar sequence of events to transmit hormone occupancy to catalytic stimulation, but that they differ quantitatively, presumably as a result of differing rate constants governing the partial reactions involved in receptor-cyclase coupling.
In the future, the scheme outlined in Fig. 1 may prove too great an oversimplification, and the multiple possible partial reactions outlined by may have to be more rigorously explored. The defined reconstitution of purified components that comprise the systems for activating and attenuating adenylate cyclase, a goal that will not easily be attained, will no doubt allow the unequivocal resolution of the following questions.
(1) What is the molecular stoichiometry of a functioning adenylate cyclase system, and do changes in the overall stoichiometry of the system and/or in the subunit stoichiometry within the G-protein complex alter the extent of responsiveness of adenylate cyclase to different effectors? (2) What are the molecular inter-relationships of the components of activating and attenuating adenylate cyclase systems? (3) Does the requirement for a hydrolysable guanine nucleotide triphosphate in the inhibition by GTP of adenylate cyclase, in hormonal attenuation of adenylate cyclase and in desensitization of adenylate cyclase in certain cell-free systems (Bockaert et al., 1976; Ezra & Salomon, 1980) reflect an underlying shared molecular mechanism for these three processes? (4) What is the molecular basis for desensitization of adenylate cyclase? (5) What is the relationship between protein-mediated events in receptor-cyclase coupling and lipid-mediated events, if any? (6) What other catalytic activities might components, or component complexes, of the adenylate cyclase system possess (e.g. methyltransferase, phospholipase or GTPase functions)? (7) What is the mechanism for regulation of adenylate cyclase by Mg2+ (Cech et al., 1981) and other divalent cations and for activation of the adenylate cyclase system by NaF? (8) Finally, does the ubiquitous association of GTP-binding proteins with the regulatory function of GTP hydrolysis (Caskey et al., 1972; Karr et al., 1979; Shinozawa et al., 1979) suggest that the adenylate-cyclase-coupled G-protein may represent a macromolecular cue that synchronizes hormonestimulation with other, apparently unrelated, cellular functions?
